Advanced Endoscopic Imaging in Colonoscopy (AEI)
A Prospective Randomized Clinical Trial to Assess the Utility of Advanced Endoscopic Imaging and the Impact of New Technologies on Quality in Colonic Examinations
The aim of the study is to evaluate the usefulness of high-tech endoscopy in clinical practice.
The important elements of this evaluation are:
- Evaluation of the character of neoplastic lesions in the colon based on different imaging techniques
- Verification of the endoscopic image with histopathologic descriptions
- Establishing the type of the lesion on the basis of Kudo and NICE classifications
- Comparison of the result of histopathological examination with the macroscopic type of the lesion
- Determination of the most advanced lesions (MAL)
- Comparison of the cecal intubation time
- Evaluation of the type of anesthesia used during colonoscopy
- Subjective assessment of the severity of pain according to VAS (visual analogue scale)
- Comparison of the accuracy of the location of lesions on the basis of endoscopic navigation
- Comparison of the total examination time
- Comparison of adenoma detection rate
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Miroslaw Szura, MD, PhD
- Phone Number: 609210030
- Email: msszura@gmail.com
Study Contact Backup
- Name: Artur Pasternak, MD, PhD
- Phone Number: 603642620
- Email: artur.pasternak@uj.edu.pl
Study Locations
-
-
Malopolska
-
Krakow, Malopolska, Poland, 30-307
- Recruiting
- Specialist Diagnostic and Therapeutic Center MEDICINA
-
Contact:
- Miroslaw Szura, Md, PhD
- Phone Number: +48 609210030
- Email: msszura@gmail.com
-
Contact:
- Artur Pasternak, MD, PhD
- Phone Number: +48 603642620
- Email: artur.pasternak@uj.edu.pl
-
Principal Investigator:
- Rafal Solecki, MD, PhD
-
Principal Investigator:
- Artur Pasternak, MD, PhD
-
Principal Investigator:
- Michal Zelek, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- written informed consent
- no previous abdominal surgery
- no colonoscopy during last 10 years
Exclusion Criteria:
- age < 40 and > 65 years
- large bowel resection in history
- colonoscopy performed during last 10 years
- contraindications for general anaesthesia
- ASA > IV
- pregnancy
- confirmed neoplastic disease
- cirrhosis (Child B or C) or ascites
- immunosuppressive therapy or steroids intake
- malabsorption syndrome
- IBD
- GI neoplastic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Conventional colonoscopy
Conventional colonoscopy performed without innovative techniques assessed in this study.
|
Conventional colonoscopy performed without innovative techniques used in experimental arm.
|
|
Experimental: Innovative colonoscopy
Innovative colonoscopy performed using narrow band imaging and dual focus function (NBI + Dual Focus)
|
NBI and Dual Focus options will be used to classify lesions according to Kudo and NICE classifications.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of innovative colonoscopy
Time Frame: 1 year
|
Diagnostic accuracy of innovative techniques used during colonoscopy (narrow band imaging and double focus option) will be assessed using StatSoft Statistica 10.0 software.
All lesions will be classified acc. to NICE and Kudo classification during colonoscopy and results will be compared with histologic examination.
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total examination time
Time Frame: 8-20 minutes
|
Time of the whole procedure (from insertion of the colonoscope to removing of the whole instrument) will be compared in conventional and innovative colonoscopy.
|
8-20 minutes
|
|
Cecal intubation time
Time Frame: 5-15 minutes
|
Time from insertion of colonoscope to visualisation of the coecum - always confirmed by a snapshot.
|
5-15 minutes
|
|
Pain intensity (VAS scale)
Time Frame: immediately after colonoscopy, 15 min, 30 min, 1 hour and 2 hours after the procedure
|
Pain intensity will be assessed during and after each colonoscopy using the Visual Analogue Scale.
It will be assessed immediately after colonoscopy, 15 min, 30 min, 1 hour and 2 hours after the procedure.
|
immediately after colonoscopy, 15 min, 30 min, 1 hour and 2 hours after the procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Miroslaw Szura, MD, PhD, Department of Experimental and Clinical Surgery, Jagiellonian University Medical College,
- Study Chair: Artur Pasternak, MD, PhD, Department of Anatomy, Jagiellonian University Medical College
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- ADVANCED ENDOSCOPIC IMAGING
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.